Quality-of-life considerations in treatment of unresectable, recurrent head and neck cancer
- PMID: 20214516
- DOI: 10.1586/era.10.13
Quality-of-life considerations in treatment of unresectable, recurrent head and neck cancer
Abstract
Recurrent, unresectable head and neck squamous cancer is a complex problem. Evidence for the efficacy of treatment is scant in this area and given the large number of patient and tumor variables involved in the recurrent tumor, several factors play a role in deciding the choice of management. The results of treatment are very poor and associated with significant toxicity. Thus, the quality of life outcome following treatment should play a major role in the choice of treatment. Unfortunately, generation of quality-of-life data is hampered by several factors, not least of which are the ethical issues raised by end of life care. This article reviews the relevant literature, summarizes existing evidence and draws conclusions, identifies gaps in the knowledge and offers guidance for further research.
Similar articles
-
Improving end-of-life care for head and neck cancer patients.Expert Rev Anticancer Ther. 2012 Mar;12(3):335-43. doi: 10.1586/era.12.6. Expert Rev Anticancer Ther. 2012. PMID: 22369325 Review.
-
[Palliative intraoperative irradiation of recurrent neck lymph node metastases in the head and neck area].Laryngorhinootologie. 1997 Jan;76(1):36-41. doi: 10.1055/s-2007-997383. Laryngorhinootologie. 1997. PMID: 9156507 German.
-
Re-irradiation with concurrent chemotherapy in recurrent head and neck cancer: a decision analysis model based on a systematic review.Clin Otolaryngol. 2008 Aug;33(4):331-7. doi: 10.1111/j.1749-4486.2008.01738.x. Clin Otolaryngol. 2008. PMID: 18983342
-
[Assessment of the quality of life of patients with incurable head-neck tumors].Laryngorhinootologie. 1989 May;68(5):285-9. doi: 10.1055/s-2007-998335. Laryngorhinootologie. 1989. PMID: 2472802 German.
-
A structured review and theme analysis of papers published on 'quality of life' in head and neck cancer: 2000-2005.Oral Oncol. 2007 Oct;43(9):843-68. doi: 10.1016/j.oraloncology.2007.02.006. Epub 2007 Jun 27. Oral Oncol. 2007. PMID: 17600755 Review.
Cited by
-
Increased sMICA and TGFβ1 levels in HNSCC patients impair NKG2D-dependent functionality of activated NK cells.Oncoimmunology. 2015 May 29;4(11):e1055993. doi: 10.1080/2162402X.2015.1055993. eCollection 2015 Nov. Oncoimmunology. 2015. PMID: 26451327 Free PMC article.
-
Using PROMs to guide patients and practitioners through the head and neck cancer journey.Patient Relat Outcome Meas. 2017 Nov 8;8:133-142. doi: 10.2147/PROM.S129012. eCollection 2017. Patient Relat Outcome Meas. 2017. PMID: 29184455 Free PMC article. Review.
-
Current management of advanced resectable oral cavity squamous cell carcinoma.Clin Exp Otorhinolaryngol. 2011 Mar;4(1):1-10. doi: 10.3342/ceo.2011.4.1.1. Epub 2011 Mar 17. Clin Exp Otorhinolaryngol. 2011. PMID: 21461056 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical